IT1254361B - Pharmaceutical formulation for topical use indicated for the treatment of viral infections of the skin and the mucosa - Google Patents

Pharmaceutical formulation for topical use indicated for the treatment of viral infections of the skin and the mucosa

Info

Publication number
IT1254361B
IT1254361B ITRM920351A ITRM920351A IT1254361B IT 1254361 B IT1254361 B IT 1254361B IT RM920351 A ITRM920351 A IT RM920351A IT RM920351 A ITRM920351 A IT RM920351A IT 1254361 B IT1254361 B IT 1254361B
Authority
IT
Italy
Prior art keywords
pharmaceutical formulation
topical use
mucosa
skin
treatment
Prior art date
Application number
ITRM920351A
Other languages
Italian (it)
Inventor
Evaristo Bertone
Original Assignee
Boniscontro E Gazzone S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boniscontro E Gazzone S R L filed Critical Boniscontro E Gazzone S R L
Priority to ITRM920351A priority Critical patent/IT1254361B/en
Publication of ITRM920351A0 publication Critical patent/ITRM920351A0/en
Publication of ITRM920351A1 publication Critical patent/ITRM920351A1/en
Application granted granted Critical
Publication of IT1254361B publication Critical patent/IT1254361B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical formulation for topical use characterised in that the active ingredient, 9-(2-hydroxyethoxymethyl) guanine (aciclovir) or a salt or derivative thereof included within it, is distributed between two phases, an aqueous phase and a lipid phase. The aciclovir is completely dissolved in the aqueous phase, while it is homogeneously dispersed in the lipid phase. Special surfactants (polysorbate 80, triethanolamine stearate), a buffer (piperazine tartrate) and a humectant (sorbitol) in high concentration are used in order to obtain a therapeutically effective concentration of dissolved aciclovir in the aqueous phase.
ITRM920351A 1992-05-11 1992-05-11 Pharmaceutical formulation for topical use indicated for the treatment of viral infections of the skin and the mucosa IT1254361B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITRM920351A IT1254361B (en) 1992-05-11 1992-05-11 Pharmaceutical formulation for topical use indicated for the treatment of viral infections of the skin and the mucosa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920351A IT1254361B (en) 1992-05-11 1992-05-11 Pharmaceutical formulation for topical use indicated for the treatment of viral infections of the skin and the mucosa

Publications (3)

Publication Number Publication Date
ITRM920351A0 ITRM920351A0 (en) 1992-05-11
ITRM920351A1 ITRM920351A1 (en) 1993-11-11
IT1254361B true IT1254361B (en) 1995-09-14

Family

ID=11400996

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM920351A IT1254361B (en) 1992-05-11 1992-05-11 Pharmaceutical formulation for topical use indicated for the treatment of viral infections of the skin and the mucosa

Country Status (1)

Country Link
IT (1) IT1254361B (en)

Also Published As

Publication number Publication date
ITRM920351A0 (en) 1992-05-11
ITRM920351A1 (en) 1993-11-11

Similar Documents

Publication Publication Date Title
ES554967A0 (en) A PROCEDURE FOR PREPARING A PHARMACEUTICAL FORMULATION CONTAINING A 2'3'-DIDESOXI-NUCLEOSIDE.
ES8305363A1 (en) Topical formulations of 9-(2-hydroxyethoxymethyl) guanine.
HK1003978A1 (en) Composition for the treatment of schizophrenia
KR870010862A (en) Nasal Aqueous Steroid Formulations
DE69317444D1 (en) ANTIVIRAL TOPICAL PHARMACEUTICAL COMPOSITIONS
IT1170214B (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIOPATHIES
MX9200728A (en) ADAPTED PHARMACEUTICAL FORMULATION FOR ADAPTED PHARMACEUTICAL FORMULATION FOR TOPICAL ADMINISTRATION, FOR SKIN DISORDERS. TOPICAL ION, FOR SKIN DISORDERS.
DK326586A (en) ANTIVIRAL PYRIMIDIDE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS AND PREPARATIONS OF THE COMPOSITIONS
WO1999012545A3 (en) Medicaments containing acyclovir
DK0773782T3 (en) Terpene derivatives (sarcodictyins) use as antitumor agents
IT1254361B (en) Pharmaceutical formulation for topical use indicated for the treatment of viral infections of the skin and the mucosa
ES2091941T3 (en) ANTINEOPLASIC EFFECT ENHANCER AND ANTINEOPLASIC AGENT.
EP0351215A3 (en) Ester of 9-(2-hydroxyethoxymethyl) guanine
MC1930A1 (en) ANTIVIRAL PRODUCT
DK0593562T3 (en) Topical preparation containing penciclovir
MY110074A (en) Pharmacuetical formulation.
ES2101311T3 (en) USE OF A TRANSDERMIC DEVICE CONTAINING (E) -2- (P-FLUOROFENETIL) -3-FLUOROALILAMINA AND ITS USE FOR THE TREATMENT OF ALZHEIMER DISEASE.
IT1257884B (en) PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT OF VASCULAR PERIPHERAL DISEASES BASED ON VINCAMINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT.
ITRM920173A1 (en) IBUPROFEN-BASED COMPOSITION FOR ORAL USE.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960514